Non-medical authorisation of blood components (NMA)

In 2022 a revised framework to support the authorisation of blood components by non-medical healthcare professionals was published. The Clinical Decision-Making and Authorising Blood Component Transfusion Framework includes: 

  • guidance around making the clinical decision for blood component transfusion and providing the written (or otherwise documented) instruction in line with national/local guidelines and recommendations. 
  • the roles and responsibilities of HCPs and their organisations involved in non-medical authorisation of blood component transfusion. 
  • the minimum elements required for an appropriate training programme, and governance in practice to safely achieve this, and supports a structured approach across the four UK countries. 

Please note, within England there is no single provider of the NMA course.